Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2024) 99 EP828 | DOI: 10.1530/endoabs.99.EP828

1Tunis, dapartment A, tunis; 2Tunisia, dapartment A, tunis, Tunisia; 3National Institue Of Nutrition and food technology, dapartment A, tunis


Introduction: Polymedication is a major problem affecting an increasing number of patients, particularly the elderly which can be deleterious in terms of quality of life, morbidity and mortality.

Objective: The aim of the present study was to determine the prevalence of polymedication in elderly diabetic patients.

Methods: This was a descriptive cross-sectional study conducted at the Institut National de Nutrition in 2023 in diabetic patients aged over 70. Polymedication was defined as taking more than five tablets per day.

Results: We enrolled 70 diabetic patients. The mean age of the population was 73±2.4 years, with females predominating (65.1%). Diabetes was poorly controlled in 73.77% of patients, with a mean glycated hemoglobin of 10.54%±2.16. Diabetes was complicated by retinopathy in 61% of cases. Comorbidities were dominated by hypertension and dyslipidemia in 84.1% and 85.7% of patients respectively. Polymedication concerned 64% of the study population. Statins were the most prescribed pharmaceutical class (78.2%), followed by antihypertensive drugs (69.7%), oral antidiabetics 51.2%)

Conclusion: Polymedication was common among elderly diabetic subjects. This may increase the risk of drug interactions and poor compliance.

Volume 99

26th European Congress of Endocrinology

Stockholm, Sweden
11 May 2024 - 14 May 2024

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.